Lung Cancer
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
New Phase 3 data reveals that combining Imdelltra with Imfinzi slashes death risk by 58% in patients with extensive-stage small cell lung…
-
Largest U.S. study links marijuana use to lung cancer risk
WASHINGTON, July 15 — A new case-control study, the largest of its kind ever conducted in the United States, has delivered a…
-
Study Links Lung Tumor Mutation, High-Fat Diet, and Nerve Pathway to Wasting Syndrome
For the first time, researchers have mapped a direct biological chain from a specific lung tumor mutation to the nervous system, with…
-
Study: Quitting Smoking for Vaping Raises Lung Cancer Risk 56%
SEOUL — A sweeping new study out of South Korea is casting serious doubt on the idea that switching to e-cigarettes is…
-
Study: Ex-Smokers Who Vape Daily Face 56% Higher Lung Cancer Risk
SEOUL — The numbers are brutal. A 56% higher lung cancer risk for former smokers who swap cigarettes for daily vaping. Not…
-
Former Smokers Who Switch to Daily Vaping Face Double Lung Cancer Death Risk
SEOUL — A South Korean study tracking more than 4.5 million adults has produced stark numbers on vaping after quitting cigarettes. The…
-
Roche Launches Subcutaneous Lung Cancer Immunotherapy in India
MUMBAI — The needle goes in. Seven minutes later, it’s over. That is the new reality for lung cancer patients in India,…
-
Roche Launches 7-Minute Lung Cancer Injection to Replace Hour-Long IV Drips
For lung cancer patients in India, the treatment chair has been a fixed point — hours of intravenous drip, hospital waits, repeated…
-
Roche Launches 7-Minute Lung Cancer Shot in India, Replacing Hour-Long IV
MUMBAI — For lung cancer patients in India, a treatment that once meant sitting for an hour or more with an IV…
-
7-Minute Injection To Treat Lung Cancer Comes To India
MUMBAI, June 9, 2026 — infopulsetoday.com — Roche Pharma India has announced the launch of Tecentriq® (atezolizumab) SC in India, the country’s…
-
Scientists Find the Switch That Exhausts CAR T Cells in Cancer
NEW YORK, June 7, 2026 — cyberinktimes.com — Researchers have identified a master switch that exhausts CAR T cells and shown how…
-
Columbia Researchers Discover Switch That Reverses Cancer-Fighting Cell Burnout
Engineered immune cells known as CAR‑T cells have revolutionized treatment for blood cancers, yet their impact on solid tumors such as breast,…
-
New Lung Cancer Treatment Option Arrives in United States Market
On August 15, 2024, the United States Food and Drug Administration authorized the use of Lazertinib for patients diagnosed with non-small cell…
-
New Treatment Option Arrives for Non-Small Cell Lung Cancer Patients
The U.S. Food and Drug Administration authorized a new medication for non-small cell lung cancer on August 15, 2024. The drug, Lazertinib,…
-
FDA Approves Lazertinib for Lung Cancer Patients
For patients with a common form of lung cancer, a new treatment option arrived in the United States on August 15, 2024.…
-
FDA Approves Lung Cancer Drug Lazertinib After 4-Year Lag
South Korea, August 16, 2024 — cyberinktimes.com — Almost four years after South Korean regulators gave it the green light, Lazertinib has…
-
Lazertinib Approved in US for Non-Small Cell Lung Cancer Treatment
In August 2024, the U.S. Food and Drug Administration granted approval for lazertinib, expanding the therapeutic arsenal against non‑small cell lung cancer…
-
FDA Approves New Lung Cancer Drug Augtyro Despite Significant Side Effects
The U.S. Food and Drug Administration granted approval on November 15, 2023, for Repotrectinib, marketed as Augtyro, to treat a defined group…
-
New Medication Approved for Non-Small Cell Lung Cancer Treatment
Tags for Structure. Probably Include a Heading Adagrasib (Krazati) Gains FDA Approval for NSCLC Targeting KRAS G12C On December 15, 2022, the…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
-
Moderna’s mRNA Platform Enables Rapid Personalized Cancer Vaccines
-
Evaluating Skyrizi’s Efficacy and Market Position in Crohn’s Disease Care
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman: Why Medical Costs Demand an 8-Month Emergency Fund
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds